Profile

Ikarovec

Ikarovec is a pre-clinical phase gene therapy company. Our programmes are aimed at treating common eye diseases. Our technology allows for targeting multiple disease targets and pathways thereby improving efficacy and restoring sight and preventing blindness.

Status current

Associated Fund UK Innovation & Science Seed Fund

Sector Medical / Biotechnology

Website https://ikarovec.com/

Associated Team Members

More Companies in Medical / Biotechnology